Drug recall · January 17, 2018
Enoxaparin Sodium recall
Why: Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10
- Lots / codes
Lot #: 7S572, Exp. 04/2019
- Quantity
- 11,474 cartons of 10 syringes per carton
- Company
- Sanofi-Aventis U.S. LLC, Bridgewater, NJ
- Distribution
- Distributed nationwide.
- Initiated
- December 5, 2017 · Voluntary: Firm initiated
- Classified
- January 5, 2018
- Reported
- January 17, 2018
- Ended
- October 11, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Enoxaparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.